Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

December 12, 2022

Study Completion Date

February 6, 2023

Conditions
Asthma
Interventions
BIOLOGICAL

MEDI3506

Participants will receive multiple doses of MEDI3506 at dose level 1 or dose level 2

DRUG

Placebo

Participants will receive multiple doses of placebo

Trial Locations (65)

1033

Research Site, Budapest

1500

Research Site, Benoni

1888

Research Site, San Juan Bautista

2100

Research Site, Gödöllő

2113

Research Site, Johannesburg

2440

Research Site, Százhalombatta

2660

Research Site, Balassagyarmat

4000

Research Site, San Miguel de Tucumán

4001

Research Site, Durban

4091

Research Site, Durban

5500

Research Site, Mendoza

5501

Research Site, Godoy Cruz

6722

Research Site, Szeged

7500

Research Site, Cape Town

7530

Research Site, Bellville

7572

Research Site, Cape Town

7600

Research Site, Mar del Plata

7700

Research Site, Cape Town

9301

Research Site, Bloemfontein

9460

Research Site, Welkom

10717

Research Site, Berlin

19055

Research Site, Schwerin

23100

Research Site, Bychawa

23552

Research Site, Lübeck

31224

Research Site, Peine

33134

Research Site, Coral Gables

39120

Research Site, Magdeburg

43617

Research Site, Toledo

55128

Research Site, Mainz

56068

Research Site, Koblenz

59808

Research Site, Missoula

60389

Research Site, Frankfurt am Main

60596

Research Site, Frankfurt

73034

Research Site, Edmond

78006

Research Site, Boerne

86899

Research Site, Landsberg

90025

Research Site, Los Angeles

92663

Research Site, Newport Beach

93301

Research Site, Bakersfield

50010-3014

Research Site, Ames

C1121 ABE

Research Site, Buenos Aires

C1414AIF

Research Site, Buenos Aires

C1425BEN

Research Site, CABA

X5003DCE

Research Site, Córdoba

B1602DQD

Research Site, Florida

B1824KAJ

Research Site, Lanús Este

M5500GHB

Research Site, Mendoza

B1878FNR

Research Site, Quilmes

03050

Research Site, Cottbus

04357

Research Site, Leipzig

15-044

Research Site, Bialystok

85-231

Research Site, Bydgoszcz

40-648

Research Site, Katowice

30-033

Research Site, Krakow

90-302

Research Site, Lodz

20-362

Research Site, Lublin

60-214

Research Site, Poznan

33-100

Research Site, Tarnów

53-301

Research Site, Wroclaw

54-239

Research Site, Wroclaw

0002

Research Site, Pretoria

BD9 6RJ

Research Site, Bradford

CB2 0QQ

Research Site, Cambridge

HP11 2QW

Research Site, High Wycombe

W1T 6AH

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY